Session Information

  • WCLC 2021

    2021 World Conference on Lung Cancer

    Conference Program for 2021 the World Conference on Lung Cancer

    Presentation Date(s):  
    • September 8 - 14, 2021
    • Total Presentations: 1107

    All times listed are in Mountain Time MDT (UTC-6:00)

    PL - Plenary
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    WS - Workshops
    IS - Industry Symposium
    MTE - Meet the Expert
    BEDG - Brain Exchange Discussion Groups

Filter Results:

Show Only CME Accredited Sessions

  • +

    ES13 - Ethics, Costs, and Regulation of Lung Cancer*

    • 17:30 - 18:05
    • 9/14/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Health Services Research/Health Economics
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES13.01 - Immunotherapy Forever? Ideal Duration and Opportunities for De-escalation of Treatment in Lung Cancer Immunotherapy

      17:30 - 17:32  |  Presenter: Yasushi Goto

      • Abstract

      No abstract available for this presentation

    • +

      ES13.02 - Barriers for Access to Curative Lung Cancer Treatment: What Can We Do About it?

      17:32 - 17:34  |  Presenter: Timothy Hanna

      • Abstract

      No abstract available for this presentation

    • +

      ES13.03 - Financial Toxicity of Cancer Treatment: Moving the Discussion from Acknowledgement of Problems to Identifying Solutions

      17:34 - 17:36  |  Presenter: Bhawna Sirohi

      • Abstract

      No abstract available for this presentation

    • +

      ES13.04 - What Evidence Level is Enough for Approval and Reimbursement of Novel Cancer Drugs? Lessons from Lung Cancer

      17:36 - 17:38  |  Presenter: Howard West

      • Abstract

      Loading...

    • +

      ES13.05 - The Ethics of International Research

      17:38 - 17:40  |  Presenter: Rebecca D. Pentz

      • Abstract

      Loading...

    • +

      ES13.06 - Tobacco Moment: The Intersection of Tobacco Use, Health Disparities, and Inequities in Lung Cancer, Treatment, and Survival

      17:40 - 17:43  |  Presenter: Abhishek Shankar

      • Abstract

      Loading...

    • +

      ES13.07 - Live Discussion with Speakers

      17:43 - 18:05

      • Abstract

      No abstract available for this presentation

  • +

    ES14 - Liquid Biopsy and Other Non-invasive Diagnostic Modalities*

    • 18:15 - 18:50
    • 9/14/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Liquid Biopsy and Other Non-invasive Diagnostic Modalities
    • +

      ES14.01 - Incorporating ctDNA Testing into Management of Advanced NSCLC Patients

      18:15 - 18:17  |  Presenter: Natasha Leighl

      • Abstract

      No abstract available for this presentation

    • +

      ES14.02 - Technical Considerations/Pitfalls in ctDNA Testing in Advanced NSCLC Patients

      18:17 - 18:19  |  Presenter: Maria Arcila

      • Abstract

      No abstract available for this presentation

    • +

      ES14.03 - Liquid Biopsy and Early NSCLC Detection

      18:19 - 18:21  |  Presenter: Christian Rolfo

      • Abstract

      Loading...

    • +

      ES14.04 - ctDNA for Minimal Residual Disease Detection

      18:21 - 18:23  |  Presenter: Max Diehn

      • Abstract

      No abstract available for this presentation

    • +

      ES14.05 - Live Discussion with Speakers

      18:23 - 18:50

      • Abstract

      No abstract available for this presentation

  • +

    ES15 - The Impact of Implicit Biases in Oncology Care*

    • 18:15 - 18:50
    • 9/14/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Patient Advocacy
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES15.01 - The Elephant in the Room

      18:15 - 18:17  |  Presenter: Jill Feldman

      • Abstract

      No abstract available for this presentation

    • +

      ES15.02 - Implicit Bias Related to Social Determinants of Health

      18:17 - 18:19  |  Presenter: Lillian Leigh

      • Abstract

      No abstract available for this presentation

    • +

      ES15.04 - Implicit Bias in Cancer Research

      18:19 - 18:21  |  Presenter: Sigourney Bell

      • Abstract

      No abstract available for this presentation

    • +

      ES15.05 - Global Perspectives on Implicit Bias in Oncology Care: India

      18:21 - 18:23  |  Presenter: Vivek Tomar

      • Abstract

      No abstract available for this presentation

    • +

      ES15.06 - Global Perspectives on Implicit Bias in Oncology Care: Canada

      18:23 - 18:25  |  Presenter: Christina Sit

      • Abstract

      Loading...

    • +

      ES15.07 - Live Discussion with Speakers

      18:25 - 18:50

      • Abstract

      No abstract available for this presentation

  • +

    ES16 - Evolving Science for Stage I Non-small Cell Lung Cancer*

    • 19:00 - 19:35
    • 9/14/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Early Stage/Localized Disease/Ablative Therapies
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES16.01 - Pathologic Evaluation of Early Non-small Cell Lung Cancer

      19:00 - 19:02  |  Presenter: Mary Beth Beasley

      • Abstract

      No abstract available for this presentation

    • +

      ES16.02 - Surgical Strategy for Early Non-Small Cell Lung Cancer

      19:02 - 19:04  |  Presenter: Hisashi Saji

      • Abstract

      No abstract available for this presentation

    • +

      ES16.03 - Radiation Oncology in Early Stage/ Localized Disease

      19:04 - 19:06  |  Presenter: Matthias Guckenberger

      • Abstract

      No abstract available for this presentation

    • +

      ES16.04 - Insights from SABR COMET and SABR Bridge

      19:06 - 19:08  |  Presenter: Biniam Kidane

      • Abstract

      No abstract available for this presentation

    • +

      ES16.05 - Live Discussion with Speakers

      19:08 - 19:35

      • Abstract

      No abstract available for this presentation

  • +

    ES17 - TNM Staging and Drug-Related Pneumonitis*

    • 19:00 - 19:35
    • 9/14/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Staging/Pulmonary Medicine
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES17.01 - Current Anatomic Staging: Perspective of TNM Classification

      19:00 - 19:02  |  Presenter: Hisao Asamura

      • Abstract

      Loading...

    • +

      ES17.02 - Future Directions in Staging

      19:02 - 19:04  |  Presenter: Valerie Rusch

      • Abstract

      No abstract available for this presentation

    • +

      ES17.03 - Imaging of Pneumonitis

      19:04 - 19:06  |  Presenter: Mizuki Nishino

      • Abstract

      Loading...

    • +

      ES17.04 - Clinical Features of "Anti-Cancer" Drug Related Pneumonitis

      19:06 - 19:08  |  Presenter: Terufumi Kato

      • Abstract

      No abstract available for this presentation

    • +

      ES17.05 - Live Discussion with Speakers

      19:08 - 19:35

      • Abstract

      No abstract available for this presentation

  • +

    ES18 - Tumor Biology and Systems Biology - Basic and Translational Science*

    • 19:45 - 20:20
    • 9/14/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Tumor Biology and Systems Biology: Basic and Translational Science
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES18.01 - Machine Learning in Systems Approaches for Lung Cancer

      19:45 - 19:47  |  Presenter: Alex Bui

      • Abstract

      No abstract available for this presentation

    • +

      ES18.02 - Immune Alterations Associated with Progression of Bronchial Premalignant Lesions

      19:47 - 19:49  |  Presenter: Jennifer Beane

      • Abstract

      No abstract available for this presentation

    • +

      ES18.03 - The Lung Microbiome and Lung Cancer Progression

      19:49 - 19:51  |  Presenter: Leopoldo Segal

      • Abstract

      Loading...

    • +

      ES18.04 - Lung Cancer Early Detection Utilizing AI in CT Scan Image Analysis

      19:51 - 19:53  |  Presenter: Shuji Sakai

      • Abstract

      No abstract available for this presentation

    • +

      ES18.05 - Response to Therapy Utilizing AI in CT Scan Image Analysis

      19:53 - 19:55  |  Presenter: Matthew B. Schabath

      • Abstract

      Loading...

    • +

      ES18.06 - Live Discussion with Speakers

      19:55 - 20:20

      • Abstract

      No abstract available for this presentation

  • +

    ES19 - Lung Cancer on a Global Scale: Challenges and Innovations*

    • 19:45 - 20:20
    • 9/14/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Global Health
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES19.01 - Access to Targeted Therapy and Immunotherapy in Low/Medium Income (LMIC) Countries 

      19:45 - 19:47  |  Presenter: Pedro Aguiar Jr.

      • Abstract

      No abstract available for this presentation

    • +

      ES19.02 - Challenges of Lung Cancer Screening at a Global Scale 

      19:47 - 19:49  |  Presenter: Pan Chyr Yang

      • Abstract

      No abstract available for this presentation

    • +

      ES19.03 - Clinical Benefit of Medical Follow-Up and Evolution of Digital Health

      19:49 - 19:51  |  Presenter: KAISHEN CHEN

      • Abstract

      No abstract available for this presentation

    • +

      ES19.04 - Access to Biomarker Testing in Developing Countries  

      19:51 - 19:53  |  Presenter: Andres Felipe Cardona Zorrilla

      • Abstract

      No abstract available for this presentation

    • +

      ES19.05 - Global Collaboration for the Approval of New Lung Cancer Therapies Under FDA’s Project Orbis 

      19:53 - 19:55  |  Presenter: Nicole Drezner

      • Abstract

      No abstract available for this presentation

    • +

      ES19.06 - Live Discussion with Speakers

      19:55 - 20:20

      • Abstract

      No abstract available for this presentation

  • +

    ES20 - Caveats, Challenges, and Controversies in Immunotherapy of Lung Cancer: Phase II and Phase III Trials*

    • 20:30 - 21:05
    • 9/14/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Immunotherapy (Phase II/III Trials)
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES20.01 - The Statistical Imperatives of Immunotherapy Research

      20:30 - 20:32  |  Presenter: Mary Redman

      • Abstract

      No abstract available for this presentation

    • +

      ES20.02 - Charting a New Path: Defining Better Endpoints in Immune Therapy Trials in Lung Cancer

      20:32 - 20:34  |  Presenter: Sanjay Popat

      • Abstract

      Loading...

    • +

      ES20.03 - Open and Unanswered Questions for Treatment and Needed Studies: What We Do and Do Not Know

      20:34 - 20:36  |  Presenter: Nick Pavlakis

      • Abstract

      No abstract available for this presentation

    • +

      ES20.04 - Challenges to Expand Who Gets Immunotherapy

      20:36 - 20:38  |  Presenter: Lyudmila Bazhenova

      • Abstract

      No abstract available for this presentation

    • +

      ES20.05 - Live Discussion with Speakers

      20:38 - 21:05

      • Abstract

      No abstract available for this presentation

  • +

    ES21 - Screening and Early Detection in Lung Cancer*

    • 20:30 - 21:05
    • 9/14/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Education Session
    • Track: Screening and Early Detection
    *Full-length Educational talk will be available as pre-release content as of September 1. The Live Day Educational Sessions will feature brief summaries and extended live discussion with the presenters. Delegates are encouraged to watch the pre-released content prior to watching the live Educational Sessions.
    • +

      ES21.01 - The Landscape of Eligibility

      20:30 - 20:32  |  Presenter: David Baldwin

      • Abstract

      No abstract available for this presentation

    • +

      ES21.02 - Barriers to Implementing Screening

      20:32 - 20:34  |  Presenter: Giulia Veronesi

      • Abstract

      No abstract available for this presentation

    • +

      ES21.03 - Evidence and Basics to Implement a Lung Cancer Screening Program

      20:34 - 20:36  |  Presenter: Matthijs Oudkerk

      • Abstract

      No abstract available for this presentation

    • +

      ES21.04 - Future Directions: Screening and AI

      20:36 - 20:38  |  Presenter: Mario Silva

      • Abstract

      No abstract available for this presentation

    • +

      ES21.05 - Future Directions: Biomarkers and Liquid Biopsy

      20:38 - 20:40  |  Presenter: Torsten Gerriet Blum

      • Abstract

      No abstract available for this presentation

    • +

      ES21.06 - Live Discussion with Speakers

      20:40 - 21:05

      • Abstract

      No abstract available for this presentation

  • +

    PL05 - Plenary 5: Closing Plenary: Immunotherapy and Beyond: Future Directions (Japanese, Mandarin, Spanish Translation Available)

    • 21:15 - 22:15
    • 9/14/2021
    • Location: Program Auditorium
    • IASLC CME Accredited
    • Type: Plenary
    • Track: N.A.
    • +

      PL05.01 - CAR T-cell Therapy for Thoracic Cancers

      21:15 - 21:27  |  Presenter: Prasad Adusumilli

      • Abstract

      Loading...

    • +

      PL05.02 - Determinants of Immunotherapy Resistance in Lung Cancer

      21:27 - 21:39  |  Presenter: Kurt Schalper

      • Abstract

      No abstract available for this presentation

    • +

      PL05.03 - Radiation/IO Synergy/Evolving Technology

      21:39 - 21:51  |  Presenter: Ken Harada

      • Abstract

      No abstract available for this presentation

    • +

      PL05.04 - IO in the Surgical Resectable Patient

      21:51 - 22:03  |  Presenter: Jamie Chaft

      • Abstract

      No abstract available for this presentation

    • +

      PL05.05 - Live Discussion with Speakers

      22:03 - 22:13

      • Abstract

      No abstract available for this presentation

    • +

      PL05.06 - Closing Remarks

      22:13 - 22:15

      • Abstract

      No abstract available for this presentation